Stockopedia | Share Prices, Share News and Company Research

MOMENTUM
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d vs 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
GROWTH & VALUE

IMPLIED MARGIN OF SAFETY (beta)
SCREENS PASSED 2
Balance Sheet · Income Statement · Cashflow FINANCIAL SUMMARY
Year End 31st Dec 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
Revenue €m
Operating Profit €m
Net Profit €m
EPS Reported
EPS Normalised
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Last ex-div: 17th Apr, paid: 31st May more... Dividends
Dividend ps
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc €m
Working Capital €m
Net Fixed Assets €m
Net Debt €m
Book Value €m
Average Shares m
Book Value ps +18.6%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2012, Glanbia plc revenues increased 14% to EUR2.21B. Net income before extraordinary items increased 50% to EUR124.8M. Revenues reflect US Cheese and Global Nutritionals segment increase of 20% to EUR1.59B, JV's & Associates segment increase of 10% to EUR577M, USA segment increase of 15% to EUR1.59B, Ireland segment increase of 8% to EUR909M. more »

HEALTH TREND

BANKRUPTCY RISK

  EARNINGS MANIPULATION RISK

MAGIC FORMULA SCORE
B-
B-

OTHER RATIOS
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
RECENT HISTORY
Latest interim period (ended 31st Dec '12) vs. prior year
Sales Growth %
EPS Growth %
3yr Average Annualised
Sales Growth %
EPS Growth %
DPS Growth %

BROKER FORECASTS
31st Dec 2013
31st Dec 2014

Price Target: N/A Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (€) (€) (€) (€) (€) (€)
Consensus Estimate
1m Change
3m Change
4 brokers BROKER CONSENSUS & FORECAST TREND
Broker Recommendations for Glanbia
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 1 3

Named Brokers and Analysts
and 1 unnamed other

Glanbia plc incorporated is an integrated global nutritionals and dairy business company. The Company operates in three segments: US Cheese & Global Nutritionals, Dairy Ireland, and JointVentures & Associates. The Company’s products are sold in over 130 countries worldwide across 17 countries. It processes approximately six billion litres of milk per annum, manufacturing over 500,000 tons of cheese and almost 250,000 tons of dairy-based ingredients including whey. The Company has four Joint Ventures & Associates including Southwest Cheese in the United States of America, Glanbia Ingredients Ireland Limited, Glanbia Cheese in the UK and Nutricima in Nigeria. The Company manufactures and markets a range of dairy and non-dairy based nutritional solutions worldwide. During the fiscal year ended December 29, 2012, the Company’s revenues from its US Cheese & Global Nutritionals were 44%; Dairy Ireland 26%, and Joint Ventures & Associates 30% of its total revenues.

Directors: John Moloney (Mgng.Dir.) 58, Siobhan Talbot (Exec. Dir.) 48, Hugh McGuire (Exec. Dir.) , Brian Phelan (Exec. Dir.) 46, Michael Horan (Secy.) 47,

No. of Employees: 4,900 No. of Shareholders: n/a


Last Annual December 31st, 2012
Last Interim December 31st, 2012
Shares in Issue 295,475,684
Free Float 166.0m (56.2%)
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange London Stock Exchange
Eligible for an ISA? a SIPP?

Address , KILKENNY, Ireland
Web http://www.glanbia.com
Phone +353 56 7772200
Contact M Horan (Secy.)
Registrar Computershare Investor Services (Ireland) Limited
Auditors PricewaterhouseCoopers LLP

Should you buy GLB

Access GLB Analytics Now!

FREE TRIAL or TAKE THE TOUR